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In this study we determined whether dermatitis 
herpetiformis patients whose skin contained linear IgA 
deposits differ from those whose skin contained granular 
IgA deposits with regard to the presence of gluten-sen-
sitive enteropathy and with regard to the prevalence of 
certain histocompatibility antigens. We performed mul-
tiple Rubin tube intestinal biopsies on 11 patients, 6 with 
linear and 5 with granular IgA deposits. The gut biopsies 
were evaluated histopathologically in a blinded fashion. 
We found that none of the patients with linear deposits 
(5 with lamina Iucida and 1 with sub-basal lamina de-
posits) had detectable jejunal abnormalities whereas all 
of those with granular deposits had jejunal abnormali-
ties (villous atrophy and increased numbers of intraepi-
theliallymphocytes). In parallel studies HLA typing was 
performed in 10 patients with linear IgA deposits and in 
49 patients with granular deposits. Only 30% of those 
with linear deposits had HLA-B8, a prevalence not sig-
nificantly different from that of the normal population 
(24%); in contrast, 88% of those with granular deposits 
had HLA-B8, a prevalence significantly greater than in 
the normal population (p < 0.001). We therefore conclude 
that patients with linear IgA deposits have a disease 
which is pathophysiologically different from those with 
granular IgA deposits. 
Dermatitis herpetiformis (DH) is a chronic, pruritic subepi-
dermal blistering skin disease of unknown etiology. Clinically it 
presents as a pleomorphic eruption of grouped urticarial pap-
ules, plaques and vesicles predominantly affecting the extensor 
surfaces of the extremities (elbows and knees), buttocks, shoul-
ders, face and scalp, and it responds promptly to therapy with 
sulfones or sulfapyridine. Patients with DH have been shown 
to have a number of immunologic abnormalities, the most 
constant being the presence of deposits of lgA in the dermal 
papillae, often associated with the third component of comple-
ment [1-5]; such dep9sits occur at the site of earliest pathologic 
change. In addition, most DH patients have a gluten-sensitive 
enteropathy (GSE) which, although usually asymptomatic, is 
thought to play an integral role in the pathogenesis of DH. 
Treatment of many DH patients with a gluten-free diet results 
in restoration of normal small bowel mucosal architecture as 
well as complete or partial resolution of the cutaneous disease 
in those patients who are able to avoid gluten completely 
[2,6]. Finally, immunogenetic studies have demonstrated that 
(7-89% of patients with DH have the HLA-B8 haplotype, which 
is a prevalence similar to that seen in patients with ordinary 
GSE (unassociated with DH) and markedly different from that 
seen in unaffected individuals (20-25%) [7]. 
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Most immunohistologic studies have noted the existence of 
a small subgroup of DH patients whose skin disease, although 
indistinguishable from that of the bulk of patients in its clinical 
manifestations and response to therapy with sulfones, differs in 
the pattern of immunoglobulin deposition in skin [2,8,9]. In 
these individuals the bound lgA occurs in a linear band along 
the basement membrane zone (BMZ) of skin instead of the 
more usual granular lgA deposits in the dermal papillae. Im-
munoelectronmicroscopic studies have demonstrated that the 
linear deposits, as seen by immunofluorescence, may be con-
fined to the lamina Iucida of the basement membrane zone or 
are sub-basal lamina in location and associated with anchoring 
fibrils [10]. In this study we investigated this patient subgroup 
more thoroughly by assessing their gastrointestinal status with 
multiple small bowel biopsies and by determining their HLA 
types; we then compared the results obtained with those ob-
tained in simultaneously studied patients with granular lgA 
skin deposits. 
MATERIALS AND METHODS 
Patients 
The overall group consisted of 59 unrelated Caucasian patients aged 
2 to 73 yr. All but 2 patients met the clinical, histologic, and therapeutic 
diagnostic criteria for DH [2]. These criteria consisted of the presence 
of a pruritic papulovesicular eruption distributed predominantly over 
the extensor surfaces of the extremities as well as the buttocks, shoul-
. ders and posterior neck. All patients had mainly vesicular lesions but 
2 (both with linear lgA deposits) had predominantly bullous and fewer 
vesicular lesions. In these 2 patients an initial clinical diagnosis of 
bullous pemphigoid versus dermatitis herpetiformis was made. Skin 
biopsies from all patients showed subepidermal blister formation with 
prominent neutrophilic infiltration, frequently with dermal papillary 
microabcesses. AU patients (except one who refused treatment) had a 
strong dependence on sulfone or sulfapyridine therapy for control of 
their eruption. Skin biopsies showed granular IgA deposits in the 
dermal papillae or continuous band-like IgA deposits along the dermal-
epidermal junction. In most cases 3, and in 1 instance 8, skin biopsies 
were obtained from patients over a period of 6 mo to 4 yr and the 
pattern of IgA deposition did not change. 
Immunofluorescence and Immunoelectronmicroscopy 
Direct immunofluorescence (DIF). for in vivo bound immunoglobu-
lins was performed using previously described techniques and reagents 
[11]. Immunoelectronmicroscopy was performed using a previously 
described peroxidase-antiperoxidase multistep technique [10]. 
Small Bowel Biopsies 
Although many patients in the overall group had had small bowel 
biopsies in the past, multiple biopsies were performed prospectively in 
5 additional patients who had granular lgA deposits in dermal papillae 
and concurrently in 6 patients who had linear lgA deposits (5 lamina 
Iucida and 1 sub-basal lamina). None of these 11 patients had symptoms 
of small bowel disease. Biopsies were performed with a Rubin tube 
under fluoroscopy after informed consent and appropriate hematolog-
ical and clotting studies 'were obtained. The site of biopsy was the 
proximal jejunum, and from 4 to 8 pieces of t issue were obtained from 
each patient. While most of the tissue was processed for staining with 
pematoxylin and eosin, one piece from each patient was processed for 
thick section plastic embedding. All biopsies were performed without 
knowledge of the patient's type of cutaneous lgA deposits and were 
read by 2 observers independently without knowledge of the patient 
source. Intraepithelial lymphocyte counts were performed using the 
method of Fry et al [12]. 
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HLA Typing 
The lymphocytes of all 59 patients were tested using the Amos 2-
stage method [13). The control group consisted of 184 normal individ-
uals. 
Statistical A nalyses 
Statistical analysis was performed using the chi-squared method 
(14). 
RESULTS 
Immunofluorescence and Immunoelectronmicroscopy 
Forty-nine patients had granular lgA deposits in dermal 
papillae and 10 had linear IgA deposits at the dermal-epidermal 
junction. Immunoelectronmicroscopy was performed on normal 
appearing skin of 8 patients with granular deposits and in 10 
patients with linear IgA deposits. 
Granular Deposits: By immunoelectronmicroscopy, the re-
action products were confined to the dermis. lgA appeared 
bound, to a large degree, to the microfibrillar-elastic fiber 
system. Details of these structural associations are described 
elsewhere [15] (Fig 1) . 
Linear Deposits: In 5 of the 10 patients with linear lgA 
staining by DIF, the reaction products were bound in the lamina 
Iucida of the BMZ. There were no specific reaction products 
seen below the basal lamina or in the epidermis. In the remain-
ing patients the reaction products were bound beneath the 
basal lamina, in a nodular or reticular pattern. These deposits 
were limited to the area where anchoring fibrils are usually 
seen (Fig 1). 
Small Bowel Biopsies 
Patients with granular lgA skin deposits: Five patients with 
granular lgA skin deposits underwent small bowel biopsy. 
Eight piec.es of tissue were obtained from each of 4 patients and 
4 pieces of tissue were obtained from 1 patient. Biopsies from 
all patients showed evidence of villous atrophy that ranged in 
degree from mild to severe (Table 1) . Thus each 'specimen 
obtained revealed some degree of flattening of intestinal villi 
and elongation of intestinal crypts; in addition, the villous 
epithelial cells were reduced in height and had irregular nuclei 
(Fig 2). Finally, all biopsies obtained from this patient group 
contained increased numbers of lymphocytes and plasma cells 
in the lamina propria, as well as increased numbers of intra-
epithelial lymphocytes ((p < 0.001 when compared to intra-
epithelial lymphocyte counts in biopsies from patients with 
linear lgA skin deposits) Table 1). 
Patients with linear IgA shin deposits: Six patients with 
cutaneous lgA arrayed in a linear pattern (5 lamina Iucida and 
1 sub-basal lamina) had small bowel biopsies. Eight pieces of 
tissue were obtained from each of 2 patients and 4 pieces of 
tissue from each of the 4 remaining patients. All biopsies from 
all 6 patients were normal (Table I). In biopsies from these 
individuals intestinal villi, epithelial crypts and villous epithelial 
cells had a normal configuration. There was no evidence of 
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F IG 1. Schematic diagram of normal dermal-epidermal junction as 
viewed ultrastructura lly and epicting location of IgA deposits in pa-
tients with dermatitis herpetiformis. 
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TABLE I. Jn.traepitheliallymphocyte counts and villous appearance 
in. small intestinal biopsies 
IgA deposiLion 
l. Granular 
2. Granular 
3. Granular 
4. Granular 
5. Granular 
6. Linear Lamina Lucida 
7. Linear Lamina Lucida 
8. Linear Lamina Lucida 
9. Linear Lamina Lucida 
10. Linear Lamina Lucida 
ll. Linear Sub-basal la mina 
Microscopic appea r- Lymphocytes per 
a nee of villi 1000 epithelia l cells 
Partial atrophy 
Total atrophy 
Partial atrophy 
Partial atrophy 
Partial atrophy 
Normal 
Normal 
Normal 
Normal 
Normal 
Normal 
Mean 
Mean 
478 
541 
323 
44 1 
520 
461 
59 
29 
112 
85 
58 
69 
132 
FIG 2. SmaLl intestinal biopsy from a patient with granular lgA skin 
deposits showing total villous flattening, elongation of epithelial crypts, 
lymphoplasmocytic infiltration of lamina propria and intra-epithelia\ 
lymphocytes. (H&E, reduced from A X 96, B x 240). 
abnormal inflammatory cell inflltration of the lamina propri~ 
or of the villous epithelium (Fig 3). 
liLA Typing 
Of the 49 patients with cutaneous IgA present in a granul~ 
pattern, 43 (88%) were found to possess the HLA-B8 haplotyp~ 
[x2 = 67.4, p < 0.001, when compared to normals (24%)]. I~ 
contrast, only 3 of 10 (30%) patients with linear IgA deposit; 
were positive for HLA-B8 which was significantly differen\ 
(Table II) from the group with granular IgA deposits (x2 = 16.1 
p < 0.001) . When the linear group was broken down accordin~ 
to immunoelectronmicroscopic findings, 2 of 5 patients wit~ 
lamina Iucida staining were positive for HLA-B8 (x2 = 7.5, p '\ 
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FIG 3. Small intestinal biopsy from a patient with linear lgA skin 
deposits, showing normal villous archi tecture (H&E, A x 96 [reduced] 
B X 240). 
TABLE II. Prevalence of HLA -BB and small bowel villous a trophy 
in patients with DH 
In Vivo bound lgA 
Linear, lamina Iucida type 
Linear, sub-basal lamina type 
Granular type (multiple gut biopsies) 
Granular type (overall) 
"This patient was HLA-B8 negative. 
HLA-B8 
2/ 5 
1/ 5 
4/ 5 
43/49 
Villous aLro-
phy 
0/ 5 
0/1" 
5/5 
1
' In previous studies 28 of 29 patients with granulru· deposits had 
varying degrees of villous atrophy as determined by 1 or 2 biopsies 
[2). 
0.01) and 1 of 5 patients with sub-basal lamina staining was 
positive for HLA-B8 (x' = 13.8, p < 0.001) again both signifi-
cantly different from the granular lgA group. The prevalence 
of HLA-B8 in our control population was 24%. 
DISCUSSION 
Studies of large groups of DH patients have repeatedly 
demonstrated that in 80-90% of DH patients, the cutaneous 
lgA is deposited in a granular fashion concentrated at the 
dermal papillary tips, while in 10-20% of cases, the lgA is 
deposited in a linear band-like fashion along the dermal-epider-
mal junction. Yaoita and Katz have demonstrated that the 
linear band-like deposits occur in 2 distinct forms when studied 
with immunoelectronmicroscopic techniques (10]. In one type, 
the deposits are located in the lamina Iucida and in the other in 
the sub-basal lamina area associated with anchoring fibrils. In 
our experience with repeated immunoelectronmicroscopic stud-
ies, localization of the IgA is constant over a prolonged interval 
of time, whether o-r not the patient is treated during that 
interval. 
The finding of linear IgA skin deposits in patients with 
clinical and histologic features of DH has been interpreted in a 
variety of ways. Jablonska et al described 9 patients with linear 
IgA deposition who had clinical and histologic features of both 
DH and bullous pemphigoid (BP) (16]. Four of the 9 patients 
did not respond well to therapy with sulfapyridine. In 2 of these 
there was a "++" staining for IgG as well as the lgA staining. 
Small intestinal biopsies were performed in 4 cases and in 2 
slight mucosal flattening was found. These authors interpreted 
these 9 patients to represent "intermediate or mixed forms" of 
DH and BP. Provost et al recently described 2 patients with a 
pruritic vesiculobullous eruption who had IgA linear deposits 
and who responded favorably to therapy with sulfones (17). 
These authors felt that these patients had a disease more 
closely related to BP than to DH and suggested the term "IgA 
bullous pemphigoid." On the other hand, Chorzelski et al had 
previously concluded that of their fu·st 19 patients with typical 
DH as judged by clinical and histologic criteria the 5 patients 
with linear lgA deposits did not differ from the 14 with granular 
deposits either in course, clinical features, or response to sulfa-
pyridine [8]. As well, Davies, Marks, and Nuki did not distin-
guish patients with linear lgA deposits from those with granular 
deposits by clinical or histologic criteria (18]. Furthermore, Fry 
and Seah have reported that 34 of their 35 DH patients (4 of 
whom had linear lgA skin deposits) had evidence of enteropathy 
[19]. 
In view of t he above cited controversy as to the importance 
of the differences in the pattern of IgA deposition it seemed 
appropriate to investigate whether DH associated with granular 
deposits was fundamentally different from that associated with 
linear deposits. To explore this possibility we determined 
whether the patients with granular deposits differed from those 
with linear deposits with regard to the presence or absence of 
GSE and with regard to the prevalence of certain histocompat-
ibility antigens usually ·associated with GSE, namely HLA-B8. 
Om study group consisted of 59 DH patients of whom 49 had 
granu lar IgA deposits and 10 had linear deposits. The granular 
and linear subgroups could not be readily distinguished by 
clinical criteria. Of the patients in the linear subgroup, 5 had 
IgA deposits restricted to the lamina Iucida while 5 had sub-
basal lamina deposits apparently associated with dermal an-
choring fibrils. Repeated skin biopsies of all 10 patients in the 
linear subgroup showed the linear IgA pattern persisted (did 
not become gxanula1·). In the· 5 patients in whom repeated 
ultrastructural studies were peJformed the ultrastructural lo-
cal ization of the immunoreactants was also constant. 
When small bowel biopsies were performed on 5 randomly 
selected patients with granular lgA deposits and then studied 
in blind fashion it was found that all 5 had histopathologic 
evidence of gluten-sensitivity: varying degrees of villous atro-
phy, increased numbers of intraepithelial lymphocytes, and 
plasma cell infiltration of the lamina propria. In contrast, when 
6 patients in the linear subgroup were similarly studied (5 with 
lamina Iucida deposits and 1 with sub-basal lamina deposits) 
all 6 had normal gastro-intestinal histology. In parallel studies 
of HLA types of these DH subgroups, it was found that 88% of 
the patients in the granular subgroup had HLA-B8, an HLA 
type frequently associated with GSE; whereas HLA-B8 was 
found in only 30% of the linear subgroup, a frequency not 
significantly higher than in normal individuals. Thus, it seems 
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clear that patients with DH and granular lgA deposits have the 
morphologic lesion of GSE and frequently bear characteristic 
HLA antigens found in GSE. Contrariwise, patients with the 
lamina Iucida type of linear lgA deposits do not have the 
morphologic lesion of GSE and do not have a high frequency of 
GSE-associated HLA types. It is difficult to draw conclusions 
about patients with the sub-basal lamina type of linear lgA 
deposits as only one patient was studied for small intestinal 
disease. However, t he HLA data on these patients parallels that 
of the lamina Iucida types. These findings do not necessarily 
imply that DH patients with linear lgA deposits do not have a 
gastro-intestinal lesion; it only means that any gastro-intestinal 
lesion present is not likely to be GSE. 
It should be stressed that the exact nosology of this disease 
(DH with linear lgA deposits) is uncertain. Although we have 
generated evidence to indicate that its pathogenesis is probably 
different from that of the bulk of DH patients, we have decided 
to retain the name "linear DH" for purposes of communication 
since almost all of these patients have clinical features and a 
clinical course which mimic that of patients with granular 
deposits. 
In summary, the data in this paper support the view that DH 
is composed of at least 2 and probably 3 subtypes based on the 
distribution of cutaneous lgA. In the granular subgroup of 
patients, there is a strong association with GSE and the HLA-
B8 haplotype and it can be postulated that the enteropathy is 
somehow related to the IgA in the skin deposits. In the linear 
subgroup of patients, there is little or no association with GSE 
or with the HLA-B8 haplotype. 
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